间质性肺病患者临床I期非小细胞肺癌肺叶与亚肺叶切除的结局
本研究纳入796例临床I期NSCLC手术患者,其中107例经HRCT诊断ILD,比较非ILD与ILD患者及ILD患者中肺叶与亚肺叶切除的OS。ILD患者OS显著低于非ILD,但ILD患者中肺叶与亚肺叶切除OS无显著差异,亚肺叶切除可能为潜在替代选择。
要点
- ILD患者临床I期NSCLC术后OS显著低于非ILD患者
- ILD患者中肺叶与亚肺叶切除的OS无显著差异
- 亚肺叶切除可能作为ILD合并临床I期NSCLC的潜在选择
核心结论
- 亚肺叶切除可能是HRCT显示ILD的临床I期NSCLC患者的潜在替代选择。
研究设计与样本
- 回顾性分析796例连续接受肺切除的临床I期NSCLC患者,其中107例经HRCT诊断ILD。
主要发现
- 与无ILD患者相比,ILD不一致于UIP模式患者OS显著更低(HR 2.66;95%CI 1.19-5.97;P=.014)。
- 与无ILD患者相比,可能UIP或UIP模式ILD患者OS显著更低(HR 2.38;95%CI 1.76-3.21;P<.001)。
- ILD患者中肺叶切除与亚肺叶切除的OS无显著差异(HR 1.82;95%CI 0.81-4.06;P=.19)。
- 多变量Cox分析显示DLCO(HR 0.95;95%CI 0.91-0.99;P=.009)为OS独立预后因素,手术方式不是(HR 2.76;95%CI 0.83-9.16;P=.099)。
临床怎么用
- 对HRCT诊断ILD的临床I期NSCLC患者,可考虑亚肺叶切除作为替代术式。
- 术前应评估DLCO等肺功能指标以辅助预后判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Since the prognosis after standard lobectomy for non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD) is poor, we investigated the possibility of sublobar resection for the improvement of the surgical results in such patients. METHODS: Of 796 consecutive patients with clinical stage I NSCLC who underwent pulmonary resection, 107 were diagnosed with ILD using high-resolution computed tomography (HRCT). Overall survivals (OS) were compared between patients with non-ILD and those with ILD or between patients with ILD who underwent lobectomy and those who underwent sublobar resection. ILD patterns consisted of usual interstitial pneumonia (UIP), possible UIP, and inconsistent with UIP. The log-rank statistics and Cox proportional hazard models were used to test for survival differences. RESULTS: OS was significantly lower in patients with "ILD inconsistent with UIP" pattern (hazard ratio [HR], 2.66; 95% confidence interval [CI], 1.19-5.97; P = .014), or "ILD with possible UIP or UIP" patterns (HR, 2.38; 95% CI, 1.76-3.21; P < .001) compared with patients with non-ILD. No significant difference in OS was observed between patients with ILD who underwent either lobectomy or sublobar resection (HR, 1.82; 95% CI, 0.81-4.06; P = .19). Multivariable Cox analysis demonstrated diffusing capacity of the lung for carbon monoxide (HR, 0.95; 95% CI, 0.91-0.99; P = .009) and not surgical procedure (HR, 2.76; 95% CI, 0.83-9.16; P = .099), as an independent prognostic factor for OS. CONCLUSIONS: Sublobar resection may be a potential alternative choice for clinical stage I NSCLC with ILD on HRCT.
引用
- Tsutani Y, Mimura T, Kai Y, et al. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg. 2017. PMID: 28483268. doi:10.1016/j.jtcvs.2017.03.116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。